Furosemide
NDC 10135-834, FUROSEMIDE, tablet, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-834
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA018569
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-834 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FUROSEMIDE80 mg/1
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-834-01 | 10135083401 | 100 TABLET in 1 BOTTLE (10135-834-01) |
| 10135-834-05 | 10135083405 | 500 TABLET in 1 BOTTLE (10135-834-05) |
| 10135-834-90 | 10135083490 | 90 TABLET in 1 BOTTLE (10135-834-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4bd1b15e-354e-051f-e063-6294a90a3f3b
Use it
Look up 10135-834 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-834 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-834. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.